TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Swetrade Pharmaceuticals AB
Closing information (x1000 DKK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
1,805
|
1,630
|
1,335 |
Financial expenses |
0
|
30
|
0 |
Earnings before taxes |
92
|
60
|
107 |
EBITDA |
90
|
27
|
107 |
Total assets |
1,310
|
1,410
|
1,277 |
Current assets |
1,226
|
1,326
|
1,153 |
Current liabilities |
249
|
446
|
284 |
Equity capital |
664
|
569
|
554 |
- share capital |
67
![]() |
67
|
73 |
Employees (average) |
2
![]() |
2
![]() |
2 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
50.7%
|
40.4%
|
43.4% |
Turnover per employee |
902
|
815
|
668 |
Profit as a percentage of turnover |
5.1%
|
3.7%
|
8.0% |
Return on assets (ROA) |
7.0%
|
6.4%
|
8.4% |
Current ratio |
492.4%
|
297.3%
|
406.0% |
Return on equity (ROE) |
13.9%
|
10.5%
|
19.3% |
Change turnover |
167
|
404
|
-324 |
Change turnover % |
10%
|
33%
|
-20% |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
0%
![]() |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.